| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 357166-50-8 | 2-Acetyl-4-Chloro-6-Nitrophenyl 4-Chlorobenzoate | C15H9Cl2NO5 |
| 357166-51-9 | 2-Acetyl-4-Chloro-6-Nitrophenyl 4-Aminobenzoate | C15H11ClN2O5 |
| 357166-56-4 | 1-(5-Chloro-2-Hydroxy-3-Nitrophenyl)-3-(4-Nitrophenyl)-1,3-Propanedione | C15H9ClN2O7 |
| 357166-57-5 | 1-(5-Chloro-2-Hydroxy-3-Nitrophenyl)-3-(4-Chlorophenyl)-1,3-Propanedione | C15H9Cl2NO5 |
| 357166-58-6 | 1-(4-Aminophenyl)-3-(5-Chloro-2-Hydroxy-3-Nitrophenyl)-1,3-Propanedione | C15H11ClN2O5 |
| 357166-84-8 | Hydroxy(2-Hydroxycyclohexyl)Acetonitrile | C8H13NO2 |
| 357172-63-5 | Morpholine [(5-methyl-1H-1,2,4-triazol-3-yl)thio]acetate | C5H7N3O2S.C4H9NO |
| 357175-33-8 | 3-Isopropenyl-7-Oxabicyclo[4.1.0]Heptane | C9H14O |
| 357179-16-9 | 1-(4,5-Dihydroxy-2-Nitrophenyl)Acetone | C9H9NO5 |
| 357187-41-8 | 6,7-Dihydroxy-4,4-Dimethyl-2-Chromanone | C11H12O4 |
| 357189-94-7 | Posaconazole 3-OXO impurity | C37H40F2N8O5 |
| 357189-95-8 | Posaconazole Impurity B | C37H40F2N8O6 |
| 357192-78-0 | 1-O-[(Z)-2-Oxido-2-(1-pyrrolidinyl)-2lambda5-diazen-1-yl]hexopyranose | C10H19N3O7 |
| 357204-95-6 | (1Z)-1-(2-Methoxyethylidene)-2-Vinylcyclopentane | C10H16O |
| 357205-17-5 | [(2R)-1-Hydroxy-3-Sulfanyl-2-Propanyl](2-Methyl-2-Propanyl)Carbamic Acid | C8H17NO3S |
| 357209-32-6 | 2,6-Bis[(3aR,8aS)-(+)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine | C25H19N3O2 |
| 357219-41-1 | 9,9-Bis(2-ethylhexyl)fluorene-2,7-bis(boronic acid pinacol ester) | C41H64B2O4 |
| 357262-90-9 | 4-Benzoyl-2-Methyl-1-[(7-Oxido-1H-Pyrrolo[2,3-b] Pyridin-3-Yl)Oxoacetyl]-Piperazine | C21H20N4O4 |
| 357263-13-9 | BMS 378806 | C22H22N4O4 |
| 357263-39-9 | (R)-2-Methyl-4-Benzoylpiperazine | C12H16N2O |
| 357263-40-2 | 4-Methoxy-1H-pyrrolo[2,3-c]pyridine | C8H8N2O |
| 357263-41-3 | 7-Chloro-1H-pyrrolo[2,3-c]pyridine | C7H5ClN2 |
| 357263-42-4 | 7-Methyl-4-azaindole | C8H8N2 |
| 357263-43-5 | 5-Chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine | C8H7ClN2 |
| 357263-48-0 | 7-Chloro-1H-pyrrolo[3,2-b]pyridine | C7H5ClN2 |
| 357263-49-1 | Methyl 7-azaindole-3-glyoxylate | C10H8N2O3 |
| 357263-59-3 | Alfa-Oxo-1H-Pyrrolo-[2,3B]Pyridine-3-Acetic Acid Monopotassium Salt | C9H5KN2O3 |
| 357272-72-1 | 6-Methylpyrazolo[1,5-a]Pyrimidine-3,5-Diamine | C7H9N5 |
| 357274-85-2 | [1-(Trifluoromethyl)vinyl]boronic acid | C3H4BF3O2 |
| 357275-54-8 | Lopinavir Metabolite M-3/M-4 | C37H48N4O6 |
| 357281-59-5 | (Cycloheptylidenehydrazinyl)Oxo-Acetonitrile | |
| 357286-30-7 | Ethyl 2-Fluoro-3-(2-Furyl)-3-Oxopropanoate | C9H9FO4 |
| 357289-65-7 | 4-Cyanofuran-2-carboxylic acid methyl ester | C7H5NO3 |
| 357290-69-8 | N-Methyl-4-Phenoxy-2-Butyn-1-Amine | C11H13NO |
| 357291-91-9 | N-[3-(Dimethylamino)Phenyl]-2-Thiophenecarboxamide | C13H14N2OS |
| 357294-38-3 | {(E)-[(Cyanocarbonyl)Hydrazono]Methyl}Benzene | C9H7N3O |
| 357294-45-2 | [[(4-Ethoxyphenyl)Methylene]Hydrazinyl]Oxo-Acetonitrile | |
| 357294-71-4 | N'-[(1E)-1-(4-Ethoxyphenyl)Ethylidene]Acetohydrazide | C12H16N2O2 |
| 357295-15-9 | N'-[(1E)-4-Cyano-2,2-Dimethylbutylidene]Acetohydrazide | C9H15N3O |
| 357295-86-4 | [[1-(2,5-Dihydroxyphenyl)Ethylidene]Hydrazinyl]Oxo-Acetonitrile | |
| 357297-08-6 | [(1-Methyl-Piperidin-4-Ylidene)Hydrazinyl]Oxo-Acetonitrile | |
| 357315-48-1 | (2Z)-2-Cyano-N-(4-Hydroxyphenyl)-3-Phenylacrylamide | C16H12N2O2 |
| 357315-51-6 | (2Z)-2-Cyano-N-(4-Hydroxyphenyl)-3-(2-Methylphenyl)Acrylamide | C17H14N2O2 |
| 357315-75-4 | (2Z)-2-Cyano-N-(4-Hydroxyphenyl)-3-(2-Methoxyphenyl)Acrylamide | C17H14N2O3 |
| 357315-80-1 | (2Z)-2-Cyano-N-(4-Hydroxyphenyl)-3-(4-Methoxyphenyl)Acrylamide | C17H14N2O3 |
| 357317-99-8 | 2-Methyl-1,3-Indolizinedicarbaldehyde | C11H9NO2 |
| 357330-15-5 | 4-Ethyl-2,2-Dimethyl-1,3-Dioxolane-4-Carbaldehyde | C8H14O3 |
| 357332-70-8 | Ethyl 2-Amino-4-Ethyl-3-Thiophenecarboxylate | C9H13NO2S |
| 357336-19-7 | (4S)-Brivaracetam | C11H20N2O2 |
| 357336-20-0 | Brivaracetam | C11H20N2O2 |